URMC / Research / Health Research /Clinical Trials / Study Details

Management of the PDA Trial

Research Question:
What is the risks and benefits of treating versus not treating babies with patent ductus arteriosus?

Basic Study Information

Purpose:
Patent ductus arteriosus (PDA) is an extra blood vessel found in babies before birth and just after birth. In most babies who have an otherwise normal heart, the PDA will shrink and close on its own in the first few days of life. If it stays open longer, it may cause extra blood to flow to the lungs. This study estimates the risks and benefits of active treatment versus expectant management of premature babies with patent ductus arteriosus.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher: Carl D'angio

Study Contact Information

Study Coordinator: Matthew Laughon, MD, MPH
Phone: (984) 974-5063
Email: matt_laughon@med.unc.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research